Your Health, We Care
Osimertinib is developed and produced by the British pharmaceutical company AstraZeneca, mainly used to treat EGFR (epidermal growth factor receptor) mutation positive non-small cell lung cancer (NSCLC) patients. As a third-generation EGFR inhibitor, it can effectively inhibit the growth of tumor cells and provide better therapeutic effects.
The Lucius version of Osimertinib generic drug has a drug specification of 80mg * 30tablets and a price of approximately $138. The price of Osimertinib versions produced by different countries and pharmaceutical companies may vary, and the specific price may be affected by various factors such as market supply and demand, exchange rate fluctuations, etc.
Osimertinib latest price in 2025Understanding how the price of osimertinib will change in 2025 is important for patients and their families who require this medication.Price differ···【more】
Article source：Lucius LaosRelease date：2025-02-27Recommended：75
How much is osimertinib a boxExploring the price of osimertinib is crucial for patients who need this drug.Price fluctuations and regional differencesThe price of osimertinib varie···【more】
Article source：Lucius LaosRelease date：2025-02-27Recommended：72
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
